Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
New research suggests pain is not a simple signal of injury but a process that unfolds across nerves, spinal cord, and brain.
A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be ...
The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results